There is a quiet mismatch in the Ayurvedic supplement world: some herbs with constant online visibility have a thinner traditional and clinical record, while Vijaysar — also known as Asana, Bijaka, Bijasara, Pterocarpus marsupium, or Indian Kino tree — remains much less familiar outside specialist circles. For metabolic health and Prameha care, Vijaysar deserves a more serious place in the conversation because classical Ayurvedic sources identify its heartwood for Prameha and meda-related disorders, and human clinical work has evaluated it in adults with type 2 diabetes.

This review keeps Vijaysar in its proper frame: not as a replacement for diabetes medication, not as a universal remedy for every form of Prameha, and not as a social-media miracle herb. Its value lies in the meeting point between classical Kapha-Medo Prameha logic, the pharmacology of its heartwood, and older but meaningful clinical trials using Vijayasar preparations in newly diagnosed or uncontrolled type 2 diabetes.

The Ayurvedic Identity of Vijaysar

The Ayurvedic Pharmacopoeia of India identifies Asana as the heartwood of Pterocarpus marsupium Roxb., family Leguminosae. The same monograph lists its Sanskrit names as Bījaka, Pītasāra, Asanaka, and Bījasāra, with common English identification as Indian Kino Tree and Hindi names including Vijayasara and Bija. The part used is the heartwood, not the leaf, bark mixture, or an unidentified wooden substitute.

Classically, Vijaysar is best understood through its drying, scraping, Kapha-reducing profile. The official Ayurvedic Pharmacopoeia profile gives its rasa as tikta and kashāya; guna as laghu and rūksha; virya as śīta; and vipāka as katu. Its listed actions include kaphapitta-śāmaka and rasāyana, and its therapeutic uses include Prameha, Medodoṣa, Pāṇḍu, Kṛmiroga, and Kuṣṭha. This makes the herb especially relevant where excess Kapha, meda, and kleda dominate the clinical picture.

The traditional practice of keeping water in a Vijaysar wooden cup overnight belongs to the same broad Ayurvedic logic as a cold infusion. Charaka’s general pharmaceutic discussion includes śīta preparations, in which a substance is kept in water overnight and used after filtration. The Ayurvedic Pharmacopoeia also notes that Asana heartwood gives a yellow-coloured solution with blue fluorescence when soaked in water, which fits the familiar colour change seen with authentic heartwood.

Why Vijaysar Fits Kapha-Medo Prameha

Prameha in Ayurveda is not a single disease label. Charaka describes twenty varieties of Prameha, grouped by doshic predominance into ten kaphaja, six pittaja, and four vataja forms. The early and more manageable presentations are Kapha-dominant, with involvement of meda, kleda, and disturbed urinary characteristics. Later or depleted patterns involve more Pitta and Vata and need different clinical judgment.

Vijaysar’s kashāya, tikta, laghu, rūksha, and śīta profile makes it a natural fit for Kapha-Medo Prameha: heaviness, excess adiposity, sluggish metabolism, excessive kleda, and insulin-resistance-like patterns. It is less suitable as a blanket recommendation for depleted, underweight, insulin-dependent, or strongly Vata-aggravated presentations unless a qualified practitioner specifically judges it appropriate. Modern diabetes categories and Ayurvedic Prameha categories are not one-to-one equivalents, so clinical supervision matters.

The Phytochemical Profile

Vijaysar heartwood contains multiple phenolic and flavonoid constituents. Modern phytochemical work has isolated flavonoid C-glucosides from its aqueous heartwood extract, and other work has described phenolic compounds such as marsupsin, pterosupin, pterostilbene, liquiritigenin, epicatechin, and related constituents. This supports the traditional preference for the heartwood and helps explain why water-based and extract-based preparations have been used in metabolic contexts.

Pterostilbene is one of the better-known compounds associated with Pterocarpus marsupium. It is structurally related to resveratrol, and an animal pharmacokinetic study reported markedly higher oral bioavailability for pterostilbene than resveratrol. Phenolic constituents from Vijaysar, including marsupsin and pterostilbene, have also been evaluated in experimental hyperglycaemia models. These findings should be read as pharmacological support for the herb’s traditional use, not as a substitute for patient-level clinical outcomes.

Laboratory work on heartwood extracts has also described antioxidant activity and improved glucose uptake in HepG2 cell models. Such cellular findings are useful for understanding possible mechanisms, but the practical Ayurvedic relevance remains centred on authenticated heartwood, correct preparation, appropriate patient selection, and careful glucose monitoring.

The Human Clinical Record

The most important human work on Vijaysar is older and less visible than many modern supplement claims, but it is directly relevant. An Indian Council of Medical Research open trial evaluated Vijayasar in newly diagnosed, previously untreated non-insulin-dependent diabetes mellitus over 12 weeks across four Indian centres. Among 93 participants who completed the trial, fasting and post-prandial blood glucose fell significantly, with mean reductions of about 32 mg/dL and 45 mg/dL respectively. Most participants achieved control with 2 g/day, while some required 3–4 g/day; routine laboratory parameters remained stable during the trial.

A later multicentre, flexible-dose, double-blind randomized trial compared Vijayasar with tolbutamide in newly diagnosed, untreated type 2 diabetes over 36 weeks. Participants received Vijayasar 2–4 g/day or tolbutamide 0.75–1.5 g/day. The published abstract reports that mean fasting and post-prandial glucose reductions were not significantly different between groups, and that glycaemic control was achieved in most participants in both arms. This places Vijaysar among the few Ayurvedic single herbs with direct human comparative data in type 2 diabetes.

Additional clinical work has examined Vijaysar as an add-on in uncontrolled type 2 diabetes and as a comparator against other herbal interventions. One open, non-randomized study used Pterocarpus marsupium wood powder at 2–4 g/day for 12 weeks in patients already taking common oral antidiabetic combinations and reported improvements in fasting glucose, post-prandial glucose, and HbA1c from baseline. A randomized single-blind comparative study in newly diagnosed type 2 diabetes evaluated Aloe vera, Vijaysar, Aloe plus Vijaysar, and glimepiride over 13 weeks, reporting glucose and HbA1c reductions in all groups, with glimepiride remaining the strongest comparator.

A broad 2022 systematic review of Ayurvedic medicines for type 2 diabetes reviewed many randomized trials across numerous Ayurvedic preparations. It was not a Vijaysar-only meta-analysis, but it helps place Vijaysar within a larger field of Ayurvedic diabetes interventions where trial quality, standardization, and adverse-event reporting still need more consistency. Vijaysar’s strongest human support remains the direct Vijayasar trials rather than broad claims borrowed from unrelated herbs.

Preparation Forms and Practical Doses

Vijaysar should be used as an authenticated heartwood preparation and not as an unidentified wooden cup or generic “diabetes wood.” The dose and form should be selected by a qualified Ayurvedic practitioner or physician, especially for anyone already taking antidiabetic medication.

Preparation Form Preparation Method Typical Use Clinical Context
Wood cup or heartwood water Water is kept overnight in an authenticated Vijaysar heartwood cup or with clean heartwood, then taken in the morning Common traditional household form; best used with practitioner guidance Traditional form; not identical to the dried extract doses used in the main ICMR trials
Heartwood decoction Heartwood is prepared as kwatha according to classical decoction principles The Ayurvedic Pharmacopoeia lists 50–100 ml as the dose of the prepared decoction (kwatha) Practitioner-supervised form, especially where stronger Kapha-Medo scraping action is desired
Dried extract or powder Authenticated Vijaysar preparation taken in measured doses Human trials commonly used flexible dosing around 2–4 g/day Best-documented form in the older clinical diabetes trials
Capsules or standardized products Commercial preparation with botanical authentication, batch testing, and clear plant-part labelling Follow the practitioner’s dose and the manufacturer’s verified composition Not automatically equivalent to trial material unless the extract type and dose match

Who Is the Best Fit for Vijaysar?

The best Ayurvedic fit is a Kapha-Medo dominant Prameha presentation: heaviness, excess adiposity, sluggish digestion, high kleda, sweet or excessive urine patterns, and early or middle-stage metabolic disturbance. This is also close to the population represented in the main human trials: adults with newly diagnosed or type 2 diabetes-like presentations, rather than children, pregnancy-related diabetes, type 1 diabetes, or advanced insulin-dependent depletion.

When the picture is dry, depleted, underweight, neuropathic, strongly Vata-aggravated, or marked by rapid weight loss and weakness, Vijaysar should not be chosen casually. Its rūksha and kashāya nature can be useful in Kapha-Medo excess but may be poorly matched to Vata depletion unless balanced within a broader formula and diet plan.

Safety, Monitoring, and Interactions

Clinical reports on Vijaysar have generally described good tolerability, but the most important safety issue is additive glucose lowering. Anyone taking metformin, sulfonylureas, insulin, GLP-1 medicines, SGLT2 inhibitors, or other diabetes drugs should add Vijaysar only with medical supervision and more frequent glucose monitoring.

  • Do not replace prescribed diabetes medication: Vijaysar is an adjunctive Ayurvedic herb, not a substitute for prescribed treatment.
  • Monitor for low blood sugar: Sweating, shaking, hunger, dizziness, confusion, palpitations, or unusual weakness need prompt glucose checking and medical advice.
  • Use caution with strong antidiabetic regimens: Insulin and sulfonylureas carry a higher hypoglycaemia risk when combined with additional glucose-lowering agents.
  • Watch digestion: Mild gastrointestinal upset can occur with many herbal preparations; persistent diarrhoea, nausea, rash, or discomfort should lead to stopping the product and consulting a clinician.
  • Special groups need direct supervision: Pregnancy, lactation, children, frail elders, kidney disease, liver disease, and complex multi-drug regimens require individualized professional advice.

Sourcing Quality Vijaysar

Quality starts with botanical identity. The product should clearly state Pterocarpus marsupium Roxb., heartwood, and preferably the Ayurvedic name Asana, Bijaka, or Bijasara. Powders, decoction material, cups, and capsules should come from licensed manufacturers that can provide batch identity, cleanliness, and heavy-metal or contaminant testing where appropriate.

A genuine wooden cup should not be treated as automatically medicinal forever. Wood can crack, absorb residues, grow mould, or be substituted with another species. If using the traditional cup method, keep it clean and dry between uses, replace it when damaged, and avoid products that do not identify the species and plant part.

Bottom Line

Vijaysar is one of the more grounded Ayurvedic herbs for Kapha-Medo Prameha and type 2 diabetes support. Its strength is the alignment of classical indication, authenticated heartwood pharmacology, and direct human clinical work using Vijayasar preparations. Used carefully, it belongs in serious Ayurvedic metabolic care; used casually, especially alongside diabetes medication, it can create avoidable risk.

For related Ayurveda reading, see Berberine and Daruharidra versus metformin, Ayurvedic adjunct support in type 1 diabetes, and metabolomics and Ayurvedic treatment validation.

This article is educational and does not diagnose, treat, or replace medical care. Vijaysar should not replace prescribed diabetes medication. Never adjust antidiabetic medication doses without physician guidance. Consult a qualified Ayurvedic practitioner or healthcare provider before starting Vijaysar, especially if pregnant, managing diabetes, taking medication, or monitoring abnormal blood glucose.

References

  1. Ayurvedic Pharmacopoeia of India
  2. Charaka Samhita — Shadvirechanashatashritiya Adhyaya
  3. Charaka Samhita — Prameha Nidana
  4. Charaka Samhita — Prameha Chikitsa
  5. Flexible dose open trial of Vijayasar in cases of newly-diagnosed non-insulin-dependent diabetes mellitus. Indian Council of Medical Research (ICMR), Collaborating Centres, New Delhi (1998), PubMed
  6. Researchgate (researchgate.net)
  7. Ijbcp (ijbcp.com)
  8. Ijbcp (ijbcp.com)
  9. Ayushdhara (ayushdhara.in)
  10. Frontiersin (frontiersin.org)
  11. Constituents of Pterocarpus marsupium: an ayurvedic crude drug (2004), PubMed
  12. Antihyperglycemic activity of phenolics from Pterocarpus marsupium (1997), PubMed
  13. Heartwood Extract of Pterocarpus marsupium Roxb. Offers Defense against Oxyradicals and Improves Glucose Uptake in HepG2 Cells (2022), PubMed Central
  14. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats (2011), PubMed